RecruitingPhase 2NCT06639984

Psyllium in Pediatric IBS

Studying CHILD syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dr Bruno Chumpitazi, M.D.
Principal Investigator
Bruno Chumpitazi, MD, MPH, MD
Duke University
Intervention
Psyllium (0.7 g/year of age per day)(drug)
Enrollment
110 target
Eligibility
12-17 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06639984 on ClinicalTrials.gov

Other trials for CHILD syndrome

Additional recruiting or active studies for the same condition.

See all trials for CHILD syndrome

← Back to all trials